Description: Taj Pharmaceuticals Ltd stands as a prominent manufacturer, exporter, and supplier of Hydroxycarbamide (Hydroxyurea) Tablets 1000mg in India, marketed under the reputable brand THAROLAX. Produced at Taj Pharma’s state-of-the-art WHO-GMP and ISO 9001:2015 certified facility in Vapi, Gujarat, these tablets are known for their high purity, safety, and therapeutic effectiveness. Hydroxycarbamide (Hydroxyurea) Tablets play a vital role in the treatment of head and neck cancer, chronic myeloid leukemia (CML), and sickle cell disease. The medicine functions by inhibiting DNA synthesis in rapidly growing cancer cells and enhancing fetal hemoglobin (HbF) levels in patients with sickle cell disease, reducing complications and improving blood flow. Recognized for its global exports across Africa, the Middle East, and Latin America (LATAM), Taj Pharmaceuticals ensures world-class manufacturing standards and affordability. The company also offers PCD Pharma Franchise opportunities across India, enabling business partners to access premium-quality oncology and hematology products. With a strong commitment to innovation, quality, and global healthcare excellence, Taj Pharmaceuticals Ltd continues to lead as the #1 trusted manufacturer and exporter of Hydroxycarbamide (Hydroxyurea) Tablets, delivering advanced and reliable healthcare solutions worldwide.
Dimensions: 1970 x 2560
File Type: jpeg
File Size: 249 KB
